机械循环支持感染的全球流行病学:IMACS登记分析
基于ISHLT机械辅助循环支持登记(IMACS)2013至2015年10171例患者,采用INTERMACS不良事件定义分析感染类型、部位与时间。感染为最常见不良事件,3788例(37%)发生至少1次感染,共报告6758次感染事件;非VAD感染最多,三类感染均多在植入后3个月内报告。
要点
- 感染为MCS患者最常见不良事件,37%患者发生至少1次感染。
- 非VAD感染最多,以肺炎、非VAD相关血流感染、尿路感染为主。
- VAD特异性感染以驱动线感染为主,三类感染均多在植入后3个月内报告。
核心结论
- 非VAD感染(肺炎、血流感染、尿路感染、胃肠道感染)是MCS患者最主要的感染类别,且多在植入后3个月内报告。
- 结果支持在MCS植入早期加强感染预防策略的资源配置。
研究设计与样本
- ISHLT机械辅助循环支持登记(IMACS)2013年1月至2015年12月全球分析,共纳入10171例患者。
- 采用INTERMACS定义对不良事件感染进行分类,并将IMACS感染变量尽可能映射至ISHLT感染定义。
- 感染分为VAD特异性、VAD相关和非VAD三类。
主要发现
- 3788例患者(37%)发生至少1次感染,共报告6758次感染不良事件。
- 非VAD感染4501次:肺炎34.0%、非VAD相关血流感染30.6%、尿路感染24.15%、胃肠道感染10.2%。
- VAD特异性感染1756次:驱动线82.9%、囊袋12.8%、泵或插管4.3%。
- VAD相关感染501次:血流感染47.5%、纵隔炎47.5%、纵隔炎/囊袋感染5.0%。
- 三类感染均更常见于植入后3个月内报告。
临床怎么用
- MCS植入后早期应重点防控非VAD感染,尤其是肺炎、血流感染和尿路感染。
- 针对驱动线感染等VAD特异性感染需加强早期预防与监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite advances in device technology and treatment strategies, infection remains a major cause of adverse events (AEs) in mechanical circulatory support (MCS) patients. To characterize the epidemiology of MCS infection, we examined the type, location, and timing of infection in the International Society for Heart and Lung Transplantation Registry (ISHLT) for Mechanically Assisted Circulatory Support (IMACS) over 3 years, 2013 to 2015. METHODS: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) definitions were used to categorize AE infections occurring in MCS patients within IMACS. The IMACS infection variables were mapped to ISHLT definitions for infection where feasible. Three categories of MCS infection were defined as ventricular assist device (VAD) specific, VAD related, and non-VAD. RESULTS: There were 10,171 patients enrolled from January 2013 through December 2015. Infection was the most common AE, with 3,788 patients (37%) experiencing ≥ 1 infection, and 6,758 AE infections reported overall. Non-VAD infection was the largest category, 4,501: 34.0% pneumonias, 30.6% non-VAD-related bloodstream infections (BSIs), 24.15% urinary tract infections (UTIs), and 10.2% gastrointestinal infections. VAD-specific infection was the second largest category, 1,756: 82.9% driveline, 12.8% pocket, and 4.3% pump/or cannula infections. VAD-related infection was the smallest category, 501: 47.5% BSIs, 47.5% mediastinitis, and 5.0% mediastinitis/pocket infections. All 3 categories were more frequently reported ≤ 3 months after implant. CONCLUSIONS: Non-VAD infection, including pneumonia, BSI, UTI, and gastrointestinal infection, was the leading category of infection in MCS patients and the most frequently reported ≤ 3 months after implant. These results provide evidence to support resourcing and strengthening infection prevention strategy early after implantation in MCS.
引用
- Hannan MM, Xie R, Cowger J, et al. Epidemiology of infection in mechanical circulatory support: A global analysis from the ISHLT Mechanically Assisted Circulatory Support Registry. J Heart Lung Transplant. 2019. PMID: 30733158. doi:10.1016/j.healun.2019.01.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。